Changes

Jump to navigation Jump to search
488 bytes added ,  01:18, November 20, 2020
On November 19, 2020, "A World Health Organization panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treat
Line 1: Line 1:  
'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]].  It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref>  Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>
 
'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]].  It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref>  Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>
   −
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. It also costs $20,000 for a treatment of it.
+
On November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>
 +
 
 +
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment.
    
In contrast, the superior and much less expensive [[hydroxychloroquine]] changes milieu in the cell and makes the [[pH]] unfavorable, such that [[mutations]] are not likely to render HCQ ineffective.
 
In contrast, the superior and much less expensive [[hydroxychloroquine]] changes milieu in the cell and makes the [[pH]] unfavorable, such that [[mutations]] are not likely to render HCQ ineffective.
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,204

edits

Navigation menu